Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation.

Journal of cell science | Jan 1, 2007

http://www.ncbi.nlm.nih.gov/pubmed/17164290

Fas ligand (FasL), a potent mediator of apoptosis expressed by CTL and NK cells, is sorted into the inner vesicles of secretory lysosomes for release via exosome-like vesicles. Previous studies identified a proline-rich domain in the cytoplasmic tail required for sorting FasL to secretory lysosomes, but the mechanisms by which this occurs have not been identified. Here we demonstrate that the PRD of FasL binds Fgr, Fyn and Lyn tyrosine kinases, leading to phosphorylation of FasL. Loss of phosphorylation reduces internalisation of FasL into multivesicular bodies. FasL is also directly mono-ubiquitylated at lysines flanking the PRD and mutation of these lysines reduces MVB localisation of FasL. Phosphorylation is not required for ubiquitylation because FasL lacking all tyrosines undergoes mono-ubiquitylation. These studies show that phosphorylation and ubiquitin signals regulate the sorting of FasL to secretory lysosomes by controlling entry into multivesicular bodies.

Pubmed ID: 17164290 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Endosomes | Fas Ligand Protein | HeLa Cells | Humans | Jurkat Cells | Leukemia, Basophilic, Acute | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | Lysosomes | Molecular Sequence Data | Phosphorylation | Protein Structure, Tertiary | Protein Transport | Proto-Oncogene Proteins | Proto-Oncogene Proteins c-fyn | Rats | Secretory Vesicles | Signal Transduction | Ubiquitin | src Homology Domains | src-Family Kinases

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.